Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. - Wikidata - wikimedia - TriplyDB

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

http://www.wikidata.org/entity/Q36772257

about

Clinical manifestations of portal hypertension Bacterial infections in cirrhosis: A critical review and practical guidance Modulation of splanchnic circulation: Role in perioperative management of liver transplant patients Acute Kidney Injury in Patients with Cirrhosis Hepatorenal syndrome: Update on diagnosis and treatment Renal failure in cirrhosis: Emerging concepts Management options in decompensated cirrhosis Acute kidney injury in patients with chronic liver disease Human albumin in the management of complications of liver cirrhosis Albumin administration in the acutely ill: what is new and where next?Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology Transjugular intrahepatic portosystemic shunt Treatment and management of ascites and hepatorenal syndrome: an update The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis Cardiovascular dysfunction in patients with liver cirrhosis Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study.A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.Urinary biomarkers of acute kidney injury in patients with liver cirrhosis.Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis.Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients.Renal dysfunction in patients with cirrhosis: Where do we stand?Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation.Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy.Urinary biomarkers and progression of AKI in patients with cirrhosis.Management of cirrhotic ascites Estimated Glomerular Filtration Rate (eGFR) Values as Predictor of Renal Insufficiency in Advanced Stages of Liver Diseases with Different Etiology.A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.Hepatorenal syndrome: aetiology, diagnosis, and treatment.How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis The combination of MELD score and ICG liver testing predicts length of stay in the ICU and hospital mortality in liver transplant recipients.Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis.Renal dysfunction in cirrhosis.

P2860

Q24633762-AF730322-C8DC-4DA5-B0F2-DB7E46B7241B Q26766663-2E132FBE-684E-452C-AF2D-5E3A6498113D Q26773222-C231D990-2F97-4CF3-8E0F-CDC4F5F10CD9 Q26775643-BB11224E-F700-4925-8B1C-1483B144F9B5 Q26777608-76B46633-C7AB-49D2-933A-82FA30C1D01D Q26785971-0DE3FAEF-CC34-4518-A09C-6DA29BB1F07B Q26800238-B5D367C2-637A-4E13-9C24-4DB0CDF0D911 Q26824834-526EACC8-3867-4909-BC6C-325087CBDAA7 Q26852608-39601D37-9F06-4B3C-95F3-4EFC59B82B07 Q26853626-6ABD0BCA-BB5A-4090-80D6-52343B8FECCB Q26853649-EE08867E-513C-421D-8BA4-C0C8941757DC Q26865028-F2EB1D51-1439-4B24-A485-F40426D0A58F Q26991832-81E2B287-30A0-471B-ADDE-3709531BF631 Q27000268-8ADA5258-8358-454F-A226-09F1206DE7D3 Q27009164-C9E4F4E7-8CFA-4EC7-A035-F5AD3C760A86 Q27010592-53271476-6D78-447F-A442-40E310CFE601 Q33364276-FBC83267-913B-4D3E-A763-4F81644FEEC0 Q33590657-8760624B-476E-490D-9FAF-A953F552BB0F Q33698303-A5909981-342A-4FA5-8254-D2773219F3C9 Q33710890-FB6CAA9B-0344-40FF-B4A5-9244ACC2F910 Q33718306-C3C9360F-86E1-42C5-89D1-62AC5B26C03A Q33786571-AA9F48EC-A2F7-4E74-AAC2-6607EF24458C Q33805260-064153B6-B5C0-4B8F-83B4-793BD7C6E60E Q33811643-423B281A-6353-4096-817B-E82C75F5C81D Q33905612-3FDA4FFA-3066-4960-9098-CD6C0B993C17 Q34027039-6A3F1F30-C0BE-4D01-87CA-5CB43918C02A Q34047665-5E9A2E1C-43E1-491F-9756-C60E4A7043AE Q34093890-8900A56C-B56B-4A4E-9E6D-AC3A70AB2943 Q34093932-6E08258A-1136-48A1-9BA2-3DA2FD6316A4 Q34213719-4341BC87-F8A7-4B05-9958-8F327C368E24 Q34455256-C845568B-236B-4236-8631-666446324BEF Q34475601-A83F06A0-1C8E-42B7-9E0D-BE7251195878 Q34556202-B4489621-A5E6-4B90-9156-1049C2E0BE15 Q34873261-3603B878-25C2-4F77-BA07-41090B75210E Q35012890-9FF630F2-0F1F-48FD-9677-53367E0B2B14 Q35185107-ABF3862B-61C8-4365-9B96-8B26F628FD7B Q35244409-946E0750-DF97-4628-A182-528482811143 Q35257636-912CD36C-F48D-452C-84D3-63D31DABEF52 Q35534087-E17F57C1-5DDE-4262-A5D3-3A956D6D83B8 Q35559713-C572AFA1-2192-4794-A659-46087D2D1C12

P2860

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

http://www.wikidata.org/entity/Q36772257

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@ast

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@en

type

label

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@ast

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@en

prefLabel

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@ast

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@en

P1433

Q36772257-DE4B696D-3676-48CC-B607-CB8F32D59ECB

P1476

Q36772257-3A6A4167-5B22-4F83-AD40-629581464515

P2093

Q36772257-1159F655-57AF-424C-BE4B-508153D40482

Q36772257-5007480E-F9B9-4306-A83A-91F78C70E178

Q36772257-77CEE280-72B8-44EC-B5BD-17CBBBA8B8A3

Q36772257-8D280E9D-9630-420A-891E-0875819F01A2

Q36772257-FCEBE4E7-BF75-4428-AD39-055567BC3D46

P2860

Q36772257-012D8CA4-5EEA-4EEC-8B1F-BA5001B16C38

Q36772257-02D41149-C763-46B3-A256-E749BF56AF61

Q36772257-034D2C45-CE93-4352-B856-1AC00EF2BFEC

Q36772257-1DAB6398-7661-4978-A89D-5308A7EAC973

Q36772257-258CFAF2-C3F2-4AD9-84EF-BDA84ACCDB6E

Q36772257-29440C62-770C-4B58-B62F-3B00C1C990F4

Q36772257-2BA30D65-6C8F-4D83-92C1-0473051CD3FB

Q36772257-2D0AC6C4-0F3D-4F8C-A3C4-44CC03A25499

Q36772257-2F15F478-5161-4A6B-A6B8-2E89D2096666

Q36772257-2F26B800-FFEF-4432-959D-B84F055EF380

P304

Q36772257-C3ECA5B3-5863-4274-80DC-003E7918F8AB

P31

Q36772257-99B7FA85-9FE9-46F7-B492-C57FE28A2742

P356

Q36772257-94008A15-0C29-4D69-92BC-7CE7AEA8E7E8

P407

Q36772257-CBF0A35A-6DDF-49BF-BC1D-8242F94BACBB

P433

Q36772257-9381FB8D-290C-48BA-A195-C08E3330E986

P478

Q36772257-615D8774-F265-47B2-9187-F4562B024CAD

P577

Q36772257-0B820D75-DA7E-4898-A664-AAE87EF315F7

P5875

Q36772257-A0974886-5C90-40D7-81C0-86C28C94CC64

P698

Q36772257-5B53417F-8E58-4855-9463-F9C79696756F

Q36772257-863264f7-d38d-4a16-ab29-203fa15642e6

P921

Q36772257-5924A833-2FBE-49F8-B20C-57506B1289BA

P932

Q36772257-8A004045-5A74-49FB-906B-CD383FFDFA54

P356

GUT.2006.107789

P1433

P1476

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

@en

P2093

Alexander Gerbes

http://www.w3.org/2001/XMLSchema#string

Florence Wong

http://www.w3.org/2001/XMLSchema#string

Francesco Salerno

http://www.w3.org/2001/XMLSchema#string

Pere Ginès

http://www.w3.org/2001/XMLSchema#string

Vicente Arroyo

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study.

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

P304

1310-1318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2006.107789

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51374672

http://www.w3.org/2001/XMLSchema#string

P698

17389705

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

1954971

http://www.w3.org/2001/XMLSchema#string